FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2740900589> ?p ?o ?g. }

• W2740900589 endingPage "e108" @default.
• W2740900589 startingPage "e107" @default.
• W2740900589 abstract "Objective: Chronic resistant peripheral neuropathies are leading disturbances in DM, CKD and PH patients .It has been known for thousand years applications of electrical energy by religious genius or unique animals such as electric fish in bottom of oceans, yoga, trancendental meditation, biofeedback approaches are reasonably somewhat effective.Design and method: 20 DM patients with peripheric neuropathies on lower limbs with severe tinglings, burnings, pains, numbness, sleeping disturbances, general or local sensing abnormalities (7 parameters),20 CKD and 10 PH patients with same symptoms included into study. Patients had severe medical treatments including analgesics, antidepressives, antianxietics, vit B complex, gabapentin like drug therapy, several types of physical therapies recently. HMTE device, HiTop 181-H (GBO Medizintechnik) applied to groups as three times a week for one hour during one month. Before study and after treatments, SBP, DBP, MAP, HR with Mobil-O-Graph NG automated continously BP recorder (APC Cardiovascular), EMG-ENG detections, HbA1c, albumin, CRP values, for sempathetic nervous system NE. E, Dopamin, PRA, aldosteron, AII levels determined. Results before and after compared acording to universal criteria. Decriments in physical symptoms cathegorised in a scale as from 10 to 1 degree decrimentally or from 1 to 10 gradually. Results: All three cathogories faced miraculous decriments at least 2 or 3 scales in peripheral symptoms on lower limbs for 7 parameters. Working and walking capacities improved dramatically and psycological behaviours changed, felt themselves like never before. SBP, DBP, MAP, HR were significantly decreased as expected at least 20% (Figure 1 and 2) .We expect hormonal values to be in accordance with dramatical clinical improvements as well. Conclusions: New treatment modality appears to have miraculous effects to be accepted officially and privately in state and private treatment centers. If we consider prevelances of 5% for DM, 8% for CKD and at least 27% for PH in world presently we believe those patients have rights to be treated in reasonable fashion with this novel modality. This is a sine qua non humanitarian task." @default.
• W2740900589 created "2017-08-08" @default.
• W2740900589 creator A5004953480 @default.
• W2740900589 creator A5013861060 @default.
• W2740900589 creator A5040804122 @default.
• W2740900589 creator A5076935377 @default.
• W2740900589 creator A5078690338 @default.
• W2740900589 creator A5082580126 @default.
• W2740900589 creator A5086895337 @default.
• W2740900589 date "2017-09-01" @default.
• W2740900589 modified "2023-10-14" @default.
• W2740900589 title "[PP.02.25] TREATMENTS OF RESISTANT PERIPHERIC POLYNEUROPATHIES WITH DIABETES MELLITUS, CHRONIC KIDNEY DISEASE PRIMARY HYPERTENSION. HIGH TONE ELECTRICAL MUSCLE STIMULATION-HTEMS" @default.
• W2740900589 doi "https://doi.org/10.1097/01.hjh.0000523263.70442.b7" @default.
• W2740900589 hasPublicationYear "2017" @default.
• W2740900589 type Work @default.
• W2740900589 sameAs 2740900589 @default.
• W2740900589 citedByCount "0" @default.
• W2740900589 crossrefType "journal-article" @default.
• W2740900589 hasAuthorship W2740900589A5004953480 @default.
• W2740900589 hasAuthorship W2740900589A5013861060 @default.
• W2740900589 hasAuthorship W2740900589A5040804122 @default.
• W2740900589 hasAuthorship W2740900589A5076935377 @default.
• W2740900589 hasAuthorship W2740900589A5078690338 @default.
• W2740900589 hasAuthorship W2740900589A5082580126 @default.
• W2740900589 hasAuthorship W2740900589A5086895337 @default.
• W2740900589 hasConcept C126322002 @default.
• W2740900589 hasConcept C134018914 @default.
• W2740900589 hasConcept C164705383 @default.
• W2740900589 hasConcept C1862650 @default.
• W2740900589 hasConcept C24998067 @default.
• W2740900589 hasConcept C2776377089 @default.
• W2740900589 hasConcept C2779901536 @default.
• W2740900589 hasConcept C46762472 @default.
• W2740900589 hasConcept C555293320 @default.
• W2740900589 hasConcept C71924100 @default.
• W2740900589 hasConcept C84393581 @default.
• W2740900589 hasConceptScore W2740900589C126322002 @default.
• W2740900589 hasConceptScore W2740900589C134018914 @default.
• W2740900589 hasConceptScore W2740900589C164705383 @default.
• W2740900589 hasConceptScore W2740900589C1862650 @default.
• W2740900589 hasConceptScore W2740900589C24998067 @default.
• W2740900589 hasConceptScore W2740900589C2776377089 @default.
• W2740900589 hasConceptScore W2740900589C2779901536 @default.
• W2740900589 hasConceptScore W2740900589C46762472 @default.
• W2740900589 hasConceptScore W2740900589C555293320 @default.
• W2740900589 hasConceptScore W2740900589C71924100 @default.
• W2740900589 hasConceptScore W2740900589C84393581 @default.
• W2740900589 hasIssue "Supplement 2" @default.
• W2740900589 hasLocation W27409005891 @default.
• W2740900589 hasOpenAccess W2740900589 @default.
• W2740900589 hasPrimaryLocation W27409005891 @default.
• W2740900589 hasRelatedWork W1490712123 @default.
• W2740900589 hasRelatedWork W2067003273 @default.
• W2740900589 hasRelatedWork W2379366035 @default.
• W2740900589 hasRelatedWork W2383009242 @default.
• W2740900589 hasRelatedWork W2394330061 @default.
• W2740900589 hasRelatedWork W2746944533 @default.
• W2740900589 hasRelatedWork W3192068728 @default.
• W2740900589 hasRelatedWork W3206997378 @default.
• W2740900589 hasRelatedWork W4252521261 @default.
• W2740900589 hasRelatedWork W4293570334 @default.
• W2740900589 hasVolume "35" @default.
• W2740900589 isParatext "false" @default.
• W2740900589 isRetracted "false" @default.
• W2740900589 magId "2740900589" @default.
• W2740900589 workType "article" @default.